معرفی
Luc Friboulet is a researcher at Gustave Roussy, Europe's leading cancer treatment center, affiliated with the UMR 981 research unit focused on molecular predictors and new targets in oncology. His work centers on understanding genetic adaptation mechanisms to kinase inhibitors, a critical area in cancer treatment resistance.
His research addresses key challenges in oncology, including:
- Identification of molecular pathways involved in drug resistance
- Development of novel therapeutic targets to overcome resistance
- Translational studies bridging molecular biology and clinical oncology
The absence of specific awards, students, or publications in the provided text suggests this information may not be publicly available in this context.
۰مقاله منتشرشده
